Filing Flows › Apyx Medical (APYX) › Q4 2025
Apyx Medical (APYX) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Mar 10, 2026
Apyx Medical (APYX) reported revenue of $19.2M for the fourth quarter 2025 (Q4 2025), +35% from a year earlier and +49% from the quarter before. Operating margin was 0.1%, net loss $1.2M (6.5% of revenue).
Apyx Medical, Q4 2025: revenue $19.2M (+35% year over year), operating margin 0.1%, net loss $1.2M, operating cash flow −$2.5M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $19.2M | +49% | +35% |
| Operating profit | $11K | — | — |
| Net earnings | −$1.2M | — | — |
| Operating cash flow | −$2.5M | — | — |
What changed
Revenue was $19.2M in Q4 2025, up 35% year over year and up 49% from the previous quarter.
Gross margin was 62.6%, down 0.4 points from a year earlier. Operating profit was $11K, a 0.1% margin (up 21.5 points year over year). Operating expenses fell 0% while revenue rose 35%. The quarter ended with a net loss of $1.2M, narrower than the previous quarter's $2.0M loss. Net interest and other expense of $1.2M was the main reason.
Operating cash flow was −$2.5M. Non-cash charges added back $221K of depreciation and amortization and $500K of share-based compensation. Working capital and other items used $2.0M. Capital expenditures of $275K exceeded it, leaving free cash flow of −$2.8M.
Questions
What was Apyx Medical's revenue in the fourth quarter 2025?
Apyx Medical (APYX) reported revenue of $19.2M for the fourth quarter 2025 (Q4 2025), +35% from a year earlier and +49% from the quarter before.
Was Apyx Medical profitable in the fourth quarter 2025?
Operating profit was $11K (0.1% of revenue) and net loss $1.2M.
Source: Apyx Medical 10-K on SEC EDGAR.